Protocol: PK Bridging ELISA for Use with Anti-Dupilumab Antibodies TZA016 and TZA017
Protocol: PK Bridging ELISA for Use with Anti-Dupilumab Antibodies TZA016 and TZA017
Download PDF
For Use with Anti-Dupilumab Monoclonal Antibodies catalog TZA016 and TZA017 coupled to a suitable SpyCatcher Reagent (e.g. #TZC002P)
This method provides a procedure for carrying out a PK ELISA with Anti-Dupilumab Antibody, TZA016 (capture antibody) and TZA017 detection antibody) coupled to a suitable SpyCatcher Reagent and using dupilumab for the standard curve. The method should always be used in conjunction with product and batch specific information provided with each vial (see product datasheets). This protocol will need to be adjusted for use with different detection methods and immunoassay technology platforms.technology platforms.
View all of our dupilumab antibodies
Reagents
- BSA (Sigma-Aldrich, A7906)
HISPEC Assay Diluent (BUF049)
Human Serum (Sigma-Aldrich, H4522)
SpyCatcher Reagents (e.g. TZC002P)
Contact us to discuss suitable options
- Phosphate buffered saline (PBS)
- 136 mM NaCl
2.68 mM KCl
8.1 mM Na2HPO4
1.46 mM KH2PO4
- PBST
- PBS with 0.05% Tween 20 (Merck Millipore, 817072)
- QuantaBlu Fluorogenic Peroxidase Substrate (Thermo Fisher Scientific, 15169)
BiSpyCatcher2:HRP (TZC002P)
Materials
- 384-well microtiter plate (black, square flat-bottom wells) for example, Black 384-Well Immuno Plates (Thermo Fisher Scientific,460518)
- Fluorescence plate reader
96-well plates can be used instead of 384-well plates (black, flat-bottom wells) for example, Black 96-Well Immuno Plates (Thermo Fisher Scientific, 437111). For the 96-well format, use 100 μl (instead of 20 μl) of antigen, antibodies, or substrate and 300 μl for the blocking step.
Method
-
Prepare the detection Anti-Dupilumab Antibody: Couple TZA017 (AbD48542ad) to suitable SpyCatcher Reagent (e.g. TZC002P) using the (Bi)SpyCatcher coupling protocol.
-
Prepare the capture Anti-Dupilumab Antibody TZA016 (AbD48333ad) at 1 μg/ml in PBS. Coat the required number of wells of a 384-well microtiter plate with 20 μl per well of the prepared capture antibody, and incubate overnight at 4°C.
-
Wash the microtiter plate five times (5x) with PBST.
-
Block the microtiter plate by adding 100 μl 5% BSA in PBST to each well, and then incubate for 1 hr at RT.
-
Wash the microtiter plate 5x with PBST.
-
For the standard curve, prepare a dilution series of dupilumab in 10% human serum in PBST in triplicate. Final concentration of dupilumab should cover the range from 0.01 ng/ml to 10,000 ng/ml. Include a zero dupilumab concentration as the background value.
-
Add 20 μl of dupilumab dilution per well (in triplicate for each standard recommended). Add 20 μl of each test sample to the other wells (in triplicate for each sample recommended). Incubate for 1 hr at RT.
-
Wash the microtiter plate 5x with PBST.
-
To each well, add 20 μl (Bi)SpyCatcher-coupled detection Anti-Dupilumab Antibody, TZA017 (AbD48542ad) at 0.5 μg/ml in PBST. Incubate for 1 hr at RT.
-
Wash the microtiter plate 10x with PBST.
-
Add 20 μl QuantaBlu Fluorogenic Peroxidase Substrate to each well and measure the fluorescence after 30 min.